Two analyses supported by the Centers for Disease Control and Prevention’s US influenza data have demonstrated that immunization reduces the risk of hospitalization in children and death in adults
Health authorities in the Democratic Republic of Congo plan to introduce a second experimental Ebola vaccine, manufactured by Johnson & Johnson, from mid-October.
The social media platform Pintrest has announced that it will introduce a new experience for vaccine-related searches, ensuring that terms such as ‘measles’ and ‘vaccine safety’ will only bring up results from public health organizations.
In a new sequencing study, researchers discovered a transcriptional signature in B cells associated with protection from SIV or HIV infection.
The first chlamydia vaccine to reach Phase I clinical trials has been observed to be safe and immunogenic in 35 women.
In a study of healthy infants, researchers discover exposure to C. difficile in infancy may provide natural immunization later in childhood.
Researchers from the University of Texas at Austin have passed an experimental RSV vaccine through Phase I human clinical trial with promising results.
Take a look at this month’s industry headlines including a US FDA approval for RECARBRIO™, positive results for XOFLUZA in children and new ACIP recommendations.
A DNA vaccine for MERS-CoV was demonstrated to be well-tolerated and immunogenic in a Phase I, first-in-human trial.
New research has revealed a dangerous stagnation in the global vaccination rates of children, owing to inequality, conflict and complacency.
